NCT02461979 The Role of the Vitamin D Receptor Gene Polymorphisms in Hepatocarcinogenesis Status UNKNOWN Phase NA
NCT02461966 Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta Status COMPLETED Phase NA
NCT02449109 Nano Drug Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02447263 HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02425735 Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02424955 Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation Status COMPLETED Phase NA
NCT02349412 Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers Status COMPLETED Phase PHASE3
NCT02333773 Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli Status COMPLETED Phase NA
NCT02329106 Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome Status COMPLETED Phase NA
NCT02324127 Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer Status UNKNOWN Phase NA
NCT02321579 Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities Status UNKNOWN Phase NA
NCT02321202 Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer Status COMPLETED Phase PHASE4
NCT02292173 Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer Status COMPLETED Phase PHASE1
NCT02291133 Treatment of Primary Liver Tumors With Electrochemotherapy (ECT) Status COMPLETED Phase PHASE1/PHASE2
NCT02271646 Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation Status COMPLETED Phase NA
NCT02264886 Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies Status COMPLETED Phase PHASE1